(MENAFN- IMARC Group) IMARC Group, a leading market research company, has recently released a report titled“ Asia Pacific Biopsy Devices Market Report by Procedure Type (Surgical Biopsy, Needle Biopsy), Product (Biopsy Guidance Systems, Needle Based Biopsy Guns, Biopsy Needles, Biopsy Forceps, and Others), Application (Breast Biopsy, Lung Biopsy, Colorectal Biopsy, Prostate Biopsy, and Others), Guidance Technique (Ultrasound-guided Biopsy, Stereotactic-guided Biopsy, MRI-guided Biopsy, and Others), End User (Hospitals and Clinics, Academic and Research Institutes, and Others), and Country 2024-2032 .” The study provides a detailed analysis of the industry, including the Asia Pacific Biopsy Devices Market Report, Share, Size, Growth and Forecast Analysis. The report also includes competitor and regional analysis and highlights the latest advancements in the market.
How Big is the Asia Pacific Biopsy Devices Market ?
The Asia Pacific biopsy devices market size reached US$ 410.5 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 821.3 Million by 2032, exhibiting a growth rate (CAGR) of 7.77% during 2024-2032.
Request For a PDF Sample Report: https://www.imarcgroup.com/asia-pacific-biopsy-devices-market/requestsample
Asia Pacific Biopsy Devices Market
The Asia Pacific biopsy device market is experiencing significant growth, driven by the increasing prevalence of cancer and other chronic diseases in the region. Additionally, as awareness and early detection of cancer among individuals increases, the demand for biopsy devices, critical for diagnosing various types of cancers is fueling the market. In line with this, the rising investments in healthcare infrastructures, along with the growing research and development activities, are further bolstering the market growth. Additionally, the expanding aging population in the region, who are more prone to chronic diseases is enabling the adoption of advanced diagnostic methods like biopsies, which is further catalyzing the regional market.
Emerging trends in the Asia Pacific biopsy devices market include the adoption of minimally invasive biopsy techniques, which offer advantages such as reduced pain, minimal scarring, and quicker recovery times compared to traditional surgical biopsies. In addition to this, the utilization of less invasive procedures is enhancing patient comfort and acceptance, thereby increasing the demand for advanced biopsy devices. Furthermore, the advancement in technology in biopsy devices, such as vacuum-assisted biopsies and image-guided biopsy systems, is improving the accuracy and efficiency of the process, which is creating a positive outlook for the market. Besides this, the elevating use of personalized medicine, where biopsy devices play a key role in obtaining tissue samples for molecular and genetic analysis, enabling targeted cancer therapies, is expected to drive the Asia Pacific biopsy devices market over the forecasted period.
Asia Pacific Biopsy Devices Market Segmentation:
Breakup by Procedure Type:
Surgical Biopsy Needle Biopsy
Breakup by Product:
Biopsy Guidance Systems Needle Based Biopsy Guns Biopsy Needles Biopsy Forceps Others
Breakup by Application:
Breast Biopsy Lung Biopsy Colorectal Biopsy Prostate Biopsy Others
Breakup by Guidance Technique:
Ultrasound-guided Biopsy Stereotactic-guided Biopsy MRI-guided Biopsy Others
Breakup by End User:
Hospitals and Clinics Academic and Research Institutes Others
Breakup by Country:
China Japan India South Korea Australia Indonesia Others
Buy Report: https://www.imarcgroup.com/checkout?id=3556&method=505
Key
Highlights
of
the
Report:
Market Performance (2018-2023) Market Outlook (2024-2032) Market Trends Market Drivers and Success Factors Impact of COVID-19 Value Chain Analysis Comprehensive mapping of the competitive
If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.
About Us:
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC's information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company's expertise.
Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.
Contact US: IMARC
Group
134
N
4th
St.
Brooklyn,
NY
11249,
USA
Email:
Tel
No:(D)
+91
120
433
0800
United
States:
+1-631-791-1145
|
United
Kingdom:
+44-753-713-2163
MENAFN26032024004122016232ID1108022214
Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.